Literature DB >> 17631594

Pain control in cancer: recent findings and trends.

D Schrijvers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17631594     DOI： 10.1093/annonc/mdm292

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study.

Authors:  Barbara Silvestri; Elena Bandieri; Salvatore Del Prete; Giovanni Pietro Ianniello; Giuseppe Micheletto; Mario Dambrosio; Giovanni Sabbatini; Luigi Endrizzi; Alessandro Marra; Enrico Aitini; Angioletta Calorio; Ferdinando Garetto; Giuseppe Nastasi; Francovito Piantedosi; Vincenzo Sidoti; Piergiorgio Spanu
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

2.  Gynaecological malignancies from palliative care perspective.

Authors:  Kamlesh Mishra
Journal:  Indian J Palliat Care       Date:  2011-01

3.  Fentanyl sublingual spray for breakthrough pain in cancer patients.

Authors:  Giovambattista Zeppetella
Journal:  Pain Ther       Date:  2013-02-19

4.  A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial.

Authors:  Qiang Liu; Yu Wang; Xiang-Jiang Luo; Ning-Ju Wang; Ping Chen; Xin Jin; Guo-Xia Mu; Xiao-Min Chai; Yue-Juan Zhang; Yu-Xiang Li; Jian-Qiang Yu
Journal:  Trials       Date:  2017-01-11       Impact factor: 2.279

5.  Substance P and beta-endorphin mediate electro-acupuncture induced analgesia in mouse cancer pain model.

Authors:  Hyo-Jeong Lee; Jae-Ho Lee; Eun-Ok Lee; Hyo-Jung Lee; Kwan-Hyun Kim; Sun-Hyung Kim; Keun-Sung Lee; Hee-Jae Jung; Sung-Hoon Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-07-16

6.  Breakthrough Cancer Pain Is Associated with Spinal Gap Junction Activation via Regulation of Connexin 43 in a Mouse Model.

Authors:  Xin Li; Siqing Jiang; Hui Yang; Qian Liao; Shousong Cao; Xuebin Yan; Dong Huang
Journal:  Front Cell Neurosci       Date:  2017-07-17       Impact factor: 5.505
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.